Published in J Biol Chem on August 28, 1998
Distinct targeting pathways for the membrane insertion of tail-anchored (TA) proteins. J Cell Sci (2008) 2.11
The structural basis of tail-anchored membrane protein recognition by Get3. Nature (2009) 1.94
Biogenesis of tail-anchored proteins: the beginning for the end? J Cell Sci (2009) 1.64
Structural insights into tail-anchored protein binding and membrane insertion by Get3. Proc Natl Acad Sci U S A (2009) 1.63
Arsenic sensing and resistance system in the cyanobacterium Synechocystis sp. strain PCC 6803. J Bacteriol (2003) 1.56
Coactivation of G protein signaling by cell-surface receptors and an intracellular exchange factor. Curr Biol (2008) 1.41
The crystal structures of yeast Get3 suggest a mechanism for tail-anchored protein membrane insertion. PLoS One (2009) 1.39
Functional Promiscuity of Homologues of the Bacterial ArsA ATPases. Int J Microbiol (2010) 0.91
In search of tail-anchored protein machinery in plants: reevaluating the role of arsenite transporters. Sci Rep (2017) 0.75
Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology (1999) 3.06
Pathology of cardiac tumors. Am J Cardiol (1968) 2.99
The role of DNA mismatch repair in platinum drug resistance. Cancer Res (1996) 2.88
Hypertensive pulmonary vascular disease in states of chronic hypoxia. J Pathol Bacteriol (1968) 2.61
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res (1999) 2.50
The role of DNA mismatch repair in drug resistance. Clin Cancer Res (1998) 2.49
Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells (1990) 2.43
Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res (1996) 2.37
Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol (1999) 2.29
Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer (1993) 2.10
Effects on the right ventricle, pulmonary vasculature, and carotid bodies of the rat of exposure to, and recovery from, simulated high altitude. Thorax (1973) 1.95
Fulvine and the pulmonary circulation. Thorax (1971) 1.94
Lichen Planus. Proc R Soc Med (1915) 1.89
Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene (1994) 1.88
Observations on the pulmonary arteries and heart weight of rats fed on Crotalaria spectabilis seeds. J Pathol Bacteriol (1966) 1.85
The histopathology of 36 cases of plexogenic pulmonary arteriopathy. Histopathology (1990) 1.85
Aminorex and the pulmonary circulation. Thorax (1971) 1.83
Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seeds. Thorax (1967) 1.69
Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells. Eur J Cancer Clin Oncol (1989) 1.68
Busulphan lung. Thorax (1969) 1.63
Electron microscopy of Crotalaria pulmonary hypertension. Thorax (1969) 1.61
Loss of DNA mismatch repair: effects on the rate of mutation to drug resistance. J Natl Cancer Inst (1997) 1.58
cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res (1988) 1.56
Electron microscopy of the plexiform lesion. Thorax (1979) 1.55
The Notch pathway in ovarian carcinomas and adenomas. Br J Cancer (2005) 1.54
Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer. Obstet Gynecol (1993) 1.52
Pulmonary veno-occlusive disease. Thorax (1971) 1.51
Post-mortem size and structure of the human carotid body. Thorax (1970) 1.50
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res (1997) 1.50
The relation between the weight of the right ventricle of the heart and the internal surface area and the number of alveoli in the human lung in emphysema. J Pathol Bacteriol (1966) 1.48
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. Clin Cancer Res (1997) 1.47
The carotid body in animals at high altitude. J Pathol (1971) 1.46
Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med (1982) 1.46
The carotid body in emphysema and left ventricular hypertrophy. J Pathol (1971) 1.45
Circulating immunoglobulin complexes in Wegener's granulomatosis. Am J Med (1976) 1.43
The small pulmonary arteries in emphysema. J Pathol Bacteriol (1965) 1.42
The relation between the weight of the right ventricle and the percentage of abnormal air space in the lung in emphysema. J Pathol Bacteriol (1966) 1.41
Electron microscopy of desquamative interstitial pneumonia. J Pathol (1969) 1.41
Necrosis of the rectum complicating agranulocytosis due to amidopyrine. Proc R Soc Med (1968) 1.39
Medical thickness of pulmonary trunk in rats with cor pulmonale induced by ingestion of Crotalaria spectabilis seeds. Cardiovasc Res (1967) 1.39
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol Cell Biol (1992) 1.39
Pulmonary veno-occlusive disease. Q J Med (1975) 1.37
Ultrastructure of hypoxic hypertensive pulmonary vascular disease. J Pathol (1977) 1.36
A pathophysiological study of 10 cases of hypoxic cor pulmonale. Q J Med (1988) 1.34
Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res (1985) 1.30
Pulmonary veno-occlusive disease. Circulation (1966) 1.30
Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res (1997) 1.29
Altitude-related deaths in seven trekkers in the Himalayas. Thorax (1983) 1.29
Identification of genes that mediate sensitivity to cisplatin. Mol Pharmacol (2001) 1.28
Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinoma. Cancer Commun (1990) 1.27
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine. Br J Cancer (2001) 1.26
Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro. Br J Cancer (1994) 1.26
The Feyrter cell in hypoxia. Thorax (1973) 1.26
Mast cells in the lungs of rats fed on Crotalaria spectabilis seeds. Am J Pathol (1967) 1.24
Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. Cancer Res (1983) 1.23
Paraquat. CRC Crit Rev Toxicol (1976) 1.22
Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck (1992) 1.22
Subacute infantile mountain sickness. J Pathol (1988) 1.22
The pathogenesis and structure of paraquat-induced pulmonary fibrosis in rats. J Pathol (1974) 1.22
Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck (2000) 1.21
Anatomical variation and quantitative histology of the normal and enlarged carotid body. J Pathol (1982) 1.20
The ultrastructure of plexogenic pulmonary arteriopathy. J Pathol (1990) 1.20
The ultrastructure and time sequence of the early stages of paraquat lung in rats. J Pathol (1974) 1.19
Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells. Int J Cancer (1991) 1.18
Extensibility of the human pulmonary trunk. Br Heart J (1965) 1.18
Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms. Transfusion (2001) 1.18
Extended CSF cytarabine exposure following intrathecal administration of DTC 101. J Clin Oncol (1993) 1.16
Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide. Cancer Res (1987) 1.16
Electron microscopy of anoxic vacuolation in the liver cell and its comparison with sucrose vacuolation. J Pathol Bacteriol (1965) 1.16
Totally implantable system for peritoneal access. J Clin Oncol (1984) 1.15
Enhanced expression and activity of DNA polymerase beta in human ovarian tumor cells: impact on sensitivity towards antitumor agents. Oncogene (2001) 1.15
Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother Pharmacol (1987) 1.13
Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy. Clin Cancer Res (2000) 1.13
The Clara cell. Thorax (1974) 1.12
Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol (1994) 1.11
Paraquat lung: a reappraisal. Thorax (1974) 1.11
Effects of chlorphentermine on the rat lung. Thorax (1973) 1.11
Role of metallothionein in carcinogenesis. Toxicol Appl Pharmacol (1994) 1.10
Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetate. J Biol Chem (1990) 1.10
The influence of age and sex on the response of the right ventricle, pulmonary vasculature and carotid bodies to hypoxia in rats. J Pathol (1974) 1.10
The small pulmonary arteries of the llama and other domestic animals native to high altitudes. Cardiovasc Res (1969) 1.09
Pulmonary vascular disease in honeycomb lung. J Pathol Bacteriol (1968) 1.09
Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatin. Mol Pharmacol (1999) 1.08
Missing link from Tibet. Thorax (1989) 1.08
Defects in cell-mediated immunity during growth of a syngeneic simian virus-induced tumor. Int J Cancer (1975) 1.07
Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies. Arch Dis Child Fetal Neonatal Ed (2001) 1.07
Electron microscopy of chlorphentermine lung. Thorax (1973) 1.06
Pulmonary hypertension complicating portal vein thrombosis. Thorax (1979) 1.06
Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153. Br J Cancer (1996) 1.06
Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis. Br J Surg (1987) 1.06
Small pulmonary arteries in some natives of La Paz, Bolivia. Thorax (1981) 1.05
Histological changes associated with ageing of the human carotid body. J Pathol (1985) 1.04
Somatostatin analogue treatment for malignant hypercalcaemia. BMJ (1990) 1.03
Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. Br J Cancer (1999) 1.03